What is OBSOLETE: Endocrine myopathy?
Endocrine myopathy is a term that was previously used to describe muscle weakness and muscle disease (myopathy) caused by disorders of the endocrine (hormone) system. This is now considered an obsolete or outdated classification in medical databases, meaning it has been replaced by more specific diagnoses. The basic idea behind endocrine myopathy is that when certain hormone-producing glands — such as the thyroid, parathyroid, adrenal glands, or pituitary gland — do not work properly, the resulting hormone imbalances can damage or weaken muscles throughout the body. Patients with endocrine myopathy typically experience progressive muscle weakness, especially in the muscles closest to the trunk of the body (proximal muscles), such as the hips, thighs, and shoulders. They may have difficulty climbing stairs, rising from a chair, or lifting their arms overhead. Other symptoms depend on which specific endocrine disorder is causing the muscle problems. For example, thyroid-related myopathy may also cause fatigue, weight changes, and sensitivity to temperature. Because this term is now obsolete, patients who were previously diagnosed with endocrine myopathy are now more accurately classified under the specific underlying endocrine condition causing their muscle disease, such as hypothyroid myopathy, hyperthyroid myopathy, steroid myopathy, or myopathy related to Cushing syndrome or hyperparathyroidism. Treatment focuses on correcting the underlying hormonal imbalance, which often leads to significant improvement or resolution of muscle symptoms.
Key symptoms:
Muscle weakness, especially in the hips, thighs, and shouldersDifficulty climbing stairsTrouble getting up from a seated positionMuscle pain or crampsFatigue and low energyMuscle wasting or loss of muscle bulkStiffness in musclesDifficulty lifting arms above the headSlow reflexesExercise intoleranceWeight changes (gain or loss depending on the hormone problem)Swelling in muscles
- Inheritance
- Variable
- Can be inherited in different ways depending on the underlying gene
- Age of Onset
- Variable
- Can begin at different ages, from infancy through adulthood
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for OBSOLETE: Endocrine myopathy.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for OBSOLETE: Endocrine myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for OBSOLETE: Endocrine myopathy.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to OBSOLETE: Endocrine myopathy.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Endocrine myopathy.
Start the conversation →Latest news about OBSOLETE: Endocrine myopathy
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for OBSOLETE: Endocrine myopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific endocrine condition is causing my muscle weakness?,How long will it take for my muscle strength to improve once treatment starts?,Will I need physical therapy to help rebuild my muscles?,Are there any activities I should avoid while my muscles are weak?,How often will I need blood tests to monitor my hormone levels?,Could my muscle weakness come back if my hormone levels change again?,Should I see both an endocrinologist and a neurologist for my care?
Common questions about OBSOLETE: Endocrine myopathy
What is OBSOLETE: Endocrine myopathy?
Endocrine myopathy is a term that was previously used to describe muscle weakness and muscle disease (myopathy) caused by disorders of the endocrine (hormone) system. This is now considered an obsolete or outdated classification in medical databases, meaning it has been replaced by more specific diagnoses. The basic idea behind endocrine myopathy is that when certain hormone-producing glands — such as the thyroid, parathyroid, adrenal glands, or pituitary gland — do not work properly, the resulting hormone imbalances can damage or weaken muscles throughout the body. Patients with endocrine my
Frequently asked questions about OBSOLETE: Endocrine myopathy
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is OBSOLETE: Endocrine myopathy?
OBSOLETE: Endocrine myopathy is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:207003). It is typically inherited as variable. Age of onset is generally variable. For verified primary sources, see the UniteRare OBSOLETE: Endocrine myopathy page.
How is OBSOLETE: Endocrine myopathy inherited?
OBSOLETE: Endocrine myopathy follows variable inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for OBSOLETE: Endocrine myopathy?
Approved treatments for OBSOLETE: Endocrine myopathy are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for OBSOLETE: Endocrine myopathy?
Active clinical trials for OBSOLETE: Endocrine myopathy are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for OBSOLETE: Endocrine myopathy?
Verified OBSOLETE: Endocrine myopathy specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full OBSOLETE: Endocrine myopathy page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.